Mack Roach III, MD, discusses the development and evaluation of a multimodal AI algorithm designed to predict prostate cancer outcomes and its performance across racial subgroups.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The chief of urologic oncology at Baptist Health's Miami Cancer Institute is speaking out on the rate of prostate cancer among Bahamian men who go undiagnosed. Dr. Murugesan Manohoran says ...

Prostate cancer often shows no early signs. An oncologist shares key symptoms men should watch for and treatment options that can improve outcomes.

The researchers wanted to determine if high-resolution micro-ultrasonography-guided biopsy was better than MRI fusion-guided biopsy for detecting prostate cancer in a clinical setting. The study found ...

Microultrasonography-guided biopsy is as effective as MRI fusion-guided biopsy for detecting Gleason Grade Group 2 or higher prostate cancer, investigators reported during a game-changing trials ...

To perform prostate cancer biopsies, doctors use a technology called MRI fusion-guided biopsy. This technique combines MRI with a transrectal ultrasound to more precisely sample prostate tissue. The ...

Targeted biopsy-only detection rates for Grade Group ≥2 were 38% with microultrasonography, 34% with MRI/US-fusion (P =0.003 for noninferiority), and 40% with microultrasonography/MRI (P <0.001 ...

Dr Jonathan Fainberg of Memorial Sloan Kettering, NY USA, will introduce an innovative way of managing focal therapy for radio-recurrent prostate cancer using the full capacity of the Koelis Trinity ® ...

The Koelis Trinity® system enables urologists to perform 3D targeted “fusion biopsy” in prostate cancer. Trinity integrates 3D ultrasound imaging with proprietary MRI-US fusion image guidance ...

News provided by Koelis Sep 20, 2024, 9:07 AM ET ...